| |
| |
|
| Insider
Information: |
Freund John Gordon |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
2,256,169 |
|
|
Indirect Shares
|
9,013,510 |
|
|
| Direct
Value |
$7,258,400 |
|
|
|
Indirect Value
|
$19,786,628 |
|
|
| Total
Shares |
11,269,679 |
|
|
| Total
Value |
$27,045,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 257.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2006-11-21 |
0 |
2009-04-17 |
2,000,936 |
Premium* |
|
|
Map Pharmaceuticals Inc |
MAPP |
Director, 10% Owner |
2011-02-14 |
1,984 |
2011-05-20 |
5,152 |
Premium* |
|
|
Mako Surgical Corp. |
MAKO |
Director |
|
0 |
2013-12-17 |
0 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
2011-02-16 |
0 |
2012-05-29 |
4,161,933 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2019-12-10 |
0 |
2019-12-10 |
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director, 10% Owner |
|
0 |
2014-02-20 |
1,208,920 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2019-11-08 |
2,175,882 |
2014-10-27 |
1,432,930 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
52,468 |
2024-05-16 |
43,413 |
Premium* |
|
|
Sutro Biopharma Inc |
STRO |
Director |
2018-10-01 |
0 |
2020-12-10 |
56,327 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
|
2023-08-09 |
25,835 |
2023-08-09 |
103,899 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2013-12-17 |
4 |
D |
$30.00 |
$68,638,530 |
I/I |
(2,287,951) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2007-10-11 |
4/A |
OE |
$14.50 |
$23,765,849 |
I/I |
1,638,798 |
1,850,993 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2007-10-11 |
4 |
OE |
$14.50 |
$23,765,834 |
I/I |
1,638,797 |
1,850,992 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-17 |
4 |
S |
$30.25 |
$20,243,688 |
I/I |
(666,200) |
524,906 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • • |
2019-08-12 |
4 |
S |
$18.25 |
$7,300,000 |
I/I |
(400,000) |
4,019,985 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-05-12 |
4 |
B |
$43.23 |
$6,354,774 |
I/I |
147,008 |
961,257 |
2.1 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
10% Owner |
– – • |
2011-02-16 |
4 |
B |
$5.00 |
$6,179,715 |
I/I |
1,235,943 |
3,877,235 |
1.5 |
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • • |
2009-08-14 |
4 |
B |
$7.25 |
$5,495,500 |
I/I |
758,000 |
3,195,249 |
2.25 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-09-11 |
4 |
S |
$10.00 |
$5,000,000 |
I/I |
(500,000) |
960,053 |
0 |
% |
|
| SIBN |
Si-Bone, Inc. |
Director |
– • • |
2018-10-19 |
4 |
B |
$15.00 |
$4,875,000 |
I/I |
325,000 |
4,419,985 |
2.25 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-09-18 |
4 |
S |
$12.00 |
$4,800,000 |
I/I |
(400,000) |
560,053 |
0 |
% |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • • |
2013-03-25 |
4 |
B |
$7.00 |
$4,767,084 |
I/I |
681,012 |
2,190,146 |
2.25 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-05-09 |
4 |
B |
$40.35 |
$4,411,286 |
I/I |
109,325 |
814,249 |
2.1 |
- |
|
| STRO |
Sutro Biopharma Inc |
Director |
– • – |
2020-08-19 |
4 |
S |
$8.72 |
$4,360,000 |
I/I |
(500,000) |
1,460,053 |
0 |
% |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-05-13 |
4 |
B |
$43.59 |
$4,228,065 |
I/I |
97,000 |
1,058,257 |
2.1 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • • |
2020-10-19 |
4 |
S |
$22.00 |
$4,181,166 |
I/I |
(190,053) |
2,129,932 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2016-07-05 |
4 |
D |
$7.03 |
$3,817,599 |
I/I |
(543,044) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-10-01 |
4 |
AS |
$20.41 |
$2,962,731 |
I/I |
(142,146) |
995,734 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-12 |
4 |
S |
$31.39 |
$2,858,859 |
I/I |
(91,072) |
1,327,046 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • • |
2019-08-26 |
4 |
S |
$18.40 |
$2,805,181 |
I/I |
(152,424) |
3,819,985 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-03-15 |
4 |
S |
$30.90 |
$2,499,586 |
I/I |
(80,887) |
1,246,159 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2009-07-08 |
4 |
B |
$19.00 |
$2,470,000 |
I/I |
130,000 |
1,188,257 |
2.1 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2020-12-02 |
4 |
S |
$23.28 |
$2,328,480 |
I/I |
(100,000) |
1,529,932 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-10-02 |
4 |
AS |
$20.72 |
$2,211,146 |
I/I |
(105,588) |
890,146 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2014-09-03 |
4 |
AS |
$15.04 |
$2,137,241 |
I/I |
(142,100) |
1,548,046 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
